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With the increasing availability and accessibility of single cell technologies, much attention
has been given to delineating the specific populations of cells present in any given tissue.
In recent years, hepatic macrophage heterogeneity has also begun to be examined using
these strategies. While previously any macrophage in the liver was considered to be a
Kupffer cell (KC), several studies have recently revealed the presence of distinct subsets of
hepatic macrophages, including those distinct from KCs both under homeostatic and
non-homeostatic conditions. This heterogeneity has brought the concept of macrophage
plasticity into question. Are KCs really as plastic as once thought, being capable of
responding efficiently and specifically to any given stimuli? Or are the differential responses
observed from hepatic macrophages in distinct settings due to the presence of multiple
subsets of these cells? With these questions in mind, here we examine what is currently
understood regarding hepatic macrophage heterogeneity in mouse and human and
examine the role of heterogeneity vs plasticity in regards to hepatic macrophage
responses in settings of both pathogen-induced and sterile inflammation.
Keywords: hepatic macrophages, Kupffer cells, inflammation, infection, recruited macrophages, liver, myeloid cellsINTRODUCTION
Macrophages, first described by Ilya Metchnikoff over 100 years ago (1), are widely recognised as
key players of the innate immune system. Macrophages are present in almost every tissue of the
body where they function to sense their local environment and to clear pathogens and debris
including dying cells. As such, macrophages are thought to be a considerably plastic cell population,
able to rapidly respond to changes in the tissue environment and to assume different cellular
phenotypes as required (2). This idea stems from findings that both in vitro bone-marrow (BM)
macrophages and in vivo macrophage populations respond differently depending on the specific
stimuli they sense in their local environment. While the plasticity of in vitro generated BM-derived
macrophages is uncontested, the recent technological advances including multi-parameter flow
cytometry/mass cytometry and single cell RNA sequencing (scRNA-seq) have demonstrated
considerable heterogeneity within the macrophage pool of different tissues, including the liver,
particularly under non-homeostatic conditions (3–8). In inflammation a population of monocytesorg June 2021 | Volume 12 | Article 6908131
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into macrophages (9, 10), which accompany the already present
tissue-resident macrophages. This has, therefore, brought the
concept of macrophage plasticity in vivo into question; is the
perceived plasticity of macrophages rather due to the presence of
different macrophage populations with distinct functions?
Moreover, while these recruited macrophages have been shown
to be able to take on a wide range of phenotypes (3, 4, 11, 12)
other recent studies have suggested that tissue-resident
macrophages (13, 14) may not respond as extensively to insults
as previously thought (4, 13–16). As the origins of tissue-resident
(primarily embryonic) and recruited macrophages (BM-derived)
differ (17–19), this also brings the role of ontogeny into question
when investigating macrophage plasticity (18). However,
whether macrophage plasticity would be inherently linked to
ontogeny or rather the length of time a macrophage spends in a
specific tissue environment or niche, where it is being continually
instructed by the other cells in that niche (20) remains an
open question.
Understanding macrophage plasticity is of crucial importance
not only to better understand macrophage fate and functions but
also in the design of therapeutic approaches aimed at
manipulating macrophage function. For example, a plastic
macrophage might represent a more amenable target in clinical
settings. Alternatively, if not plastic, the strategy to replace the
macrophage population may be more beneficial. In this review,
we thus aim to provide our viewpoint on the role of macrophage
heterogeneity vs plasticity in the context of the liver. First, we will
provide an overview of the current state-of-the-art regarding the
different macrophage populations that have been described across
different settings in the murine and human liver. Subsequently,
we will discuss what is known, alongside the remaining questions
regarding the specific roles of the distinct hepatic macrophage
populations and their associated plasticity in the context of both
pathogen-induced and sterile inflammation.HEPATIC MACROPHAGE POPULATIONS
Before we can investigate functions and potential plasticity of
hepatic macrophages in sterile and pathogen-induced
inflammation, we must first consider the different macrophage
populations present in the liver under different settings. Thus,
here we will first introduce the main subsets present across
species and inflammatory settings and the terminology by which
we will refer to them throughout this review.
Murine Hepatic Macrophages
To date, the homeostatic murine liver has been demonstrated to
harbour two distinct macrophage populations, Kupffer cells and
capsule macrophages (Figure 1). Kupffer cells (KCs), first
described by Karl Wilhelm von Kupffer (34), are the resident
macrophages of the liver, which represent one of the most
abundant macrophage populations in the body. These cells,
defined by their expression of CLEC4F, TIM4, F4/80 and
CD64 (22, 35) (Figure 1), reside in the liver sinusoids whereFrontiers in Immunology | www.frontiersin.org 2they further extend a proportion of their body to contact hepatic
stellate cells (HSCs) and hepatocytes (36). KCs are largely found
throughout the liver, however, are relatively sparse in the
immediate vicinity of the central vein (37). As has been
reviewed extensively, KCs, are long-lived, self-renewing
macrophages, that exist, at least in the mouse, largely in the
absence of any input from circulating BM (17, 19, 20). The one
exception to this is a short time window in the first weeks of life,
when the liver is growing (22). On the other hand, liver capsule
macrophages reside, as their name would suggest, in the liver
capsule (21). Here they express CD64 and F4/80, but lack
expression of CLEC4F and TIM4. Capsule macrophages are
also identified through their expression of CX3CR1 (absent on
KCs) and CD207 (langerin; also expressed by KCs) (21)
(Figure 1). Unlike KCs, capsule macrophages are relatively
short-lived and arise primarily from monocytes (21).
While relatively straight forward under homeostatic
conditions, in inflammation, the murine hepatic macrophage
pool becomes considerably more complex. Inflammation is
often linked to a reduction in the resident KC pool (4, 15, 23–
25, 32, 38, 39). However, while in some studies this has been
demonstrated numerically (4, 25, 32, 38, 39), in others this drop
in resident KCs is observed only as a reduction in proportion.
This may result from an increase in other recruited cells (e.g.,
monocytes, neutrophils) rather than a drop in numbers of
resident KCs per se (15, 23, 24). Whether in number or
proportion, this reduction in resident KCs is linked to the
recruitment of monocytes (Ly6Chi, CD11b+, F4/80-, CD64lo/int),
which rapidly differentiate into hepatic macrophages (Ly6C-,
CD11b-/+, F4/80+, CD64+). Under some conditions, these
recruited macrophages can further differentiate into recruited
KCs which can be temporally distinguished from resident KCs
based on their lack of TIM4 expression (4, 22–26, 32, 40)
(Figure 1). As recruited KCs can acquire TIM4 expression with
time (22) (Figure 1), long-term (>1month) tracking of these cells
is only possible through the use of fate-mapping methods such as
BM chimeras, parabiosis or genetically-labelled mouse models
(22). However, the use of such fate-mapping methods can also
impact the results. For example, the irradiation required to
generate BM chimeras may further injure the liver, rendering
results difficult to interpret. Irradiation may also alter disease
progression in some models. With this in mind, many studies
utilise flow cytometric methods instead which are often quicker
and less invasive. However, without a permanent marker of
origin, these studies cannot distinguish recruited KCs on the
long-term. Whether a distinction between resident and recruited
KCs is required or is rather an issue of semantics remains debated.
Recruited KCs have been shown to acquire the full transcriptional
profile of resident KCs, when generated following resident KC
depletion using Diptheria toxin administration in Clec4f-DTR
mice (22). This ability to acquire the resident KC profile is driven
by the imprinting of differentiating monocytes by the cells of the
local KC niche including liver sinusoidal endothelial cells
(LSECs), HSCs and hepatocytes (36, 41, 42). However, whether
recruited KCs developing in an inflamed environment would
receive the same imprinting and hence resemble the steady-stateJune 2021 | Volume 12 | Article 690813
Zwicker et al. Hepatic Macrophage Heterogeneity and Plasticityresident KC counterparts remains unclear. Moving forward, the
recent generation of new genetic mouse models that allow
monocyte-progeny to be fate mapped will help to resolve some
of these questions (43).
In addition to generating KCs, recruited monocytes can also
have a different fate, differentiating into macrophages distinct
from KCs (4, 15, 32). In many models where inflammation is
resolved including acetaminophen (paracetamol; APAP)
overdose induced acute liver injury, these recruited non-KC
macrophages appear to be short-lived and lost upon resolution
of inflammation (15). Thus, from herein we will refer to these
cells as recruited-temporary macrophages (Figure 1). As manyFrontiers in Immunology | www.frontiersin.org 3studies have not investigated potential macrophage
heterogeneity, the distinction between resident KCs, recruited
KCs and recruited-temporary macrophages is often not clear and
hence it remains to be seen if all these cells are a common feature
of liver inflammation. Moreover, capsule macrophage responses
in inflammation have not yet been assessed. Additionally, for
many settings we still lack specific markers for the recruited-
temporary macrophage population, making it difficult to
distinguish these cells from capsule and recruited macrophages
on their way to becoming KCs, prior to their acquisition of KC
markers such as CLEC4F, which takes ~7 days (22) (Figure 1).
Recently, CLEC2 has been proposed to be an early marker ofA
B
FIGURE 1 | Murine and Human Macrophage Populations in the Healthy and Inflamed Liver. (A) Two distinct populations of hepatic macrophages have been defined
to date in the murine liver, the resident KCs, which make up the majority of the hepatic macrophage population and a smaller population of macrophages found in
the liver capsule (21). In inflammation, these populations are often accompanied by populations of recruited macrophages. These can also exist in at least two
subsets, recruited KCs which can persist in the tissue to generate resident KCs (4, 22–26) and a population of macrophages that are lost from the liver upon
resolution of inflammation (15) here termed recruited-temporary macrophages. In the human liver, we still do not fully understand the distinct populations of
macrophages present and how these relate to those found in mice. To date no counterpart for the murine capsule macrophages has been identified, however, this
may be due to difficulties in isolating cells from the capsule, particularly from smaller liver biopsies which do not harbour significant amounts of capsule tissue. While
all macrophages in the human liver can be identified on the basis of their expression of CD68, scRNA-seq studies have revealed that these can be further split into
distinct subsets (27–30). Two populations of macrophages have been identified in healthy human liver tissue, which are distinguished by their expression of MARCO
and TIMD4. Here we speculate (shown in grey) that the MARCO+TIMD4+ cells would be the counterparts of the murine resident KCs while the cells lacking
expression of these two genes could be considered as recruited-temporary macrophages. In inflammation, a population of MARCO+TIMD4- macrophages has also
been identified thus it is tempting to align these with murine recruited KCs (30), however this also requires validation. In addition to these genes delineating subsets of
human hepatic macrophages, CD32 has also recently been suggested to be a good protein marker to distinguish between these macrophages (31). (B) Due to their
recent identification within the hepatic macrophage pool, the precise nature of the recruited-temporary macrophage population also remains unclear. In certain
inflammatory settings, such as NASH and fibrosis/cirrhosis, it has recently been shown that these cells express genes including Spp1, Gpnmb (mouse) Trem2 and
Cd9 (mouse and human). In mouse, these cells were termed lipid-associated macrophages (LAMs) while in human they were called scar-associated macrophages
(SAMs) (4, 30, 32). Alignment of the LAMs and SAMs showed significant overlap (4) suggesting these could indeed be equivalent populations. In other inflammatory
settings much less is known about these cells, and hence it is unclear if these cells also have a LAM/SAM phenotype or if their phenotype is dependent on the
inflammatory stimulus. In acute liver injury in mice, they have been suggested to express genes associated with a function in resolution as well as genes associated
with extracellular matrix (15). In human acute liver injury, a population of MerTK+CD163+ macrophages have been reported which may represent human recruited-
temporary macrophages (33). Moreover, to date, the specific functions of these cells are largely speculative. To date, limited data is available regarding recruited-
temporary macrophages in infection in mice and humans and thus their potential function(s) remain speculative.June 2021 | Volume 12 | Article 690813
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CLEC4F+ (4, 23). However, without more specific markers of the
remaining CLEC2- cells it remains difficult to identify the bona
fide recruited-temporary macrophage population(s) that may be
present (Figure 1). It should also be noted that while here we
refer to these cells as recruited-temporary macrophages, in
chronic models, it is unclear if these cells are (a) temporary
and hence lost upon resolution of inflammation or (b)
continuously replaced or persistent throughout the course of
inflammation. Given the potential role for local niche signals in
imprinting macrophage phenotype as is observed for KCs, we
would hypothesize that recruited-temporary macrophages would
be lost upon return to homeostasis as the niche inflammation is
also resolved, hence their designation as temporary, however this
remains to be tested. In metabolic-associated fatty liver disease
(MAFLD), a population of recruited-temporary macrophages
distinct from KCs and capsule macrophages called lipid
associated macrophages (LAMs) has been identified (4)
(Figure 1). These are proposed to develop through an
intermediate population termed c-LAMs (32). LAMs and c-
LAMs were found to preferentially localise in zones of fibrotic
tissue and had a transcriptional profile distinct from resident and
recruited KCs (4, 32). While the size of this population increased
with time on the diet, correlating with both weight gain and the
degree of fibrosis (4), whether this increase is due to local
proliferation or continuous engraftment has not yet been
investigated. Moreover, the fate of these cells upon return to
normal chow has not yet been studied. Taken together, in
inflammation the murine liver can harbour at least 4 distinct
populations of macrophages, resident KCs, recruited KCs,
capsule macrophages and recruited-temporary macrophages
(Figure 1). Notably, aside from the proposal of niche
availability (20), the precise micro-environmental cues
determining the fate of recruited monocytes remain unclear
(see below). Additionally, the degree of homogeneity within
the recruited-temporary macrophage pool across inflammatory
conditions remains to be investigated.
Human Hepatic Macrophages
As humans do not live in specific pathogen free (SPF) environments
with restricted diets, exactly how comparable and relevant the
homeostatic mouse hepatic macrophage populations are to those
observed in the healthy human liver is debatable. Despite this,
scRNA-seq and single nuclei sequencing (snRNA-seq) of healthy
caudate lobes of the human liver (non-transplanted tissue) have
identified two distinct populations of hepatic macrophages (27, 28)
(Figure 1). As both expressed CD68 and were found in the healthy
liver, they were both termed KCs. CD68+ MARCO+ KCs appear to
closely resemble murine resident KCs in terms of their
transcriptome (27). In addition to transcriptional similarities, like
murine resident KCs, MARCO+ macrophages were also largely
absent from peri-central regions of liver tissue, instead
predominating in peri-portal regions as assessed using
immunohistochemistry (27). Thus, MARCO+ KCs may be bona
fide human resident KCs, although identification of additional
markers expressed by these cells and conserved with murineFrontiers in Immunology | www.frontiersin.org 4resident KCs would help to support this conclusion. In addition
to the putative human resident KCs, CD68+MARCO- KCs were also
identified in the healthy human liver. These cells were enriched for
genes associated with monocytes including FCN1, S100A8 and LYZ
and showed an increased propensity for TNFa production
following stimulation with LPS and IFNg ex vivo (27). As such,
these were designated as inflammatory KCs. Similarly, another
scRNA-seq study also reported the presence of two KC
populations in the healthy human liver (29), while a third study,
using flow cytometry, suggested CD32 to be a useful surface marker
to discriminate between these two KC subsets (31). However, as
these latter two studies utilised normal tissue adjacent to resected
tumour tissue as healthy liver tissue, how representative these
macrophage populations are of those found in healthy livers
remains unclear. Notably, the CD32int subset identified as the
inflammatory KC population also expressed CD1c (29, 31) which
is a typical marker associated with human conventional type 2
Dendritic cells (cDC2s) (44–46). Thus, the designation of these cells
as KCs clearly requires further validation, as this could potentially
represent a mixed population of myeloid cells. Indeed, as KCs
defined in these 3 studies were identified as such primarily based on
their expression of CD68 and their presence in the healthy liver, it
will be important in general to validate the claim of KC identity. For
example, can we be sure that these are both KCs and one population
does not represent human capsule macrophages as observed in the
murine healthy liver? Alternatively, as even a healthy human will
likely have experienced infection, eaten fatty food or consumed
alcohol, another possibility is that these inflammatory KCs are
equivalents of the murine recruited-temporary macrophages
(Figure 1). This is especially likely when healthy liver tissue is
obtained from patients undergoing liver resection due to cancer
metastasis (29, 31). Suggesting that these MARCO- macrophages
may indeed be recruited-temporary macrophages rather than KCs,
a recent study by the Henderson lab investigating myeloid cell
heterogeneity in healthy and cirrhotic human livers foundMARCO-
CD68+ macrophages to be enriched in cirrhotic tissue (30).
Consistent with this, Marco expression in the mouse, was also
restricted to KCs in the fatty murine liver (4), although whether this
holds true in other inflammatory settings remains to be investigated.
In addition, this study also identified additional heterogeneity
within the MARCO-expressing KCs (30). Here MARCO+ KCs in
the healthy human liver (resected material) could be further divided
into two populations, one expressing TIMD4 and one lacking
expression of TIMD4 reminiscent of the murine resident and
recently recruited KC populations respectively (30) (Figure 1).
Consistent with the murine liver, in inflammation, there is
also further heterogeneity within the human hepatic macrophage
pool. In the cirrhotic liver, similar to the inflamed murine liver, a
reduction in the proportion of resident KCs (MARCO+TIMD4+)
was observed (30). This was accompanied by an increase in the
proportion of CD68+MARCO- macrophages expressing CD9 and
TREM2 which were termed Scar-associated macrophages or
SAMs due to their proximity to cirrhotic scar tissue (30). Thus,
SAMs are likely a subset of recruited-temporary macrophages in
the human liver. While the SAMs described here share some
overlap with the inflammatory KCs described above includingJune 2021 | Volume 12 | Article 690813
Zwicker et al. Hepatic Macrophage Heterogeneity and PlasticityFCN1, CD68 and LYZ expression (27, 30), the precise overlap
between these cells requires further investigation (Figure 1).
Notably, these SAMs are also reminiscent of LAMs, the
recruited-temporary macrophages recruited to the liver in
murine models of fatty liver disease (4) (Figure 1). Similar to
LAMs, the temporal nature of these SAMs remains to be
established. In addition to SAMs, a population of macrophages
expressing MerTK and preferentially localised around
centrilobular necrosis in the livers of patients following APAP
overdose have been described (33). As MerTK expression was
relatively sparse in the rest of the liver this could suggest that
these cells are a population of recruited-temporary macrophages
(Figure 1), indeed this would be consistent with the increased
expression of MerTK observed in circulating blood monocytes
of these patients compared with healthy controls (33).
Alternatively, resident KCs may upregulate MerTK expression
upon APAP overdose, as secretory leucocyte protease inhibitor
(SLPI), produced in acute liver failure, was shown to induce
MerTK expression in monocytes and hepatic macrophages (33).
Importantly, exactly how similar these cells are to the hepatic
macrophage populations described in the single cell studies
remains to be seen. Thus, taken together, it is clear further
work is required to fully understand human hepatic macrophage
heterogeneity in health and disease.HEPATIC MACROPHAGE RESPONSES:
A FUNCTION OF PLASTICITY OR
HETEROGENEITY?
Hepatic macrophages, initially considered to consist only of KCs
were thought to be very plastic cells, being rapidly able to
respond to any insult as required. However, now that we know
there are in fact many distinct subsets of hepatic macrophages
this has led us to question if this range of functions represents
bona fide plasticity of resident KCs or if it rather reflects the
heterogeneous nature of the hepatic macrophage pool in
inflammation? This question is not unique to the liver, rather
it can be asked of macrophages throughout the body. Indeed, the
plasticity of the resident alveolar macrophages in the lung has
also recently been questioned (18). However, while in that
perspective it was proposed that tissue resident alveolar
macrophages are not particularly plastic (18), as will be
discussed below, evidence from distinct hepatic inflammatory
insults would suggest this may not be the case for the resident
KCs, where there appears to be an immediate, albeit acute,
response (Figure 2). However, despite this initial response, we
similarly postulate that the assumed hepatic macrophage
plasticity observed later in the inflammatory response, is likely
a function of heterogeneity within the hepatic macrophage pool,
as recruited-temporary macrophages and to a lesser extent
recruited KCs appear to respond differently compared with
resident KCs. In addition, there is likely additional plasticity
within these recruited populations as they appear to be able to
edit their profiles according to the environment into which they
are recruited (Figure 2). Compared with KCs, very little isFrontiers in Immunology | www.frontiersin.org 5known about capsule macrophages in infection/inflammation.
Recently, these have been suggested to have a function in
immune surveillance by sensing microbes in the peritoneal
cavity and recruiting microbicidal neutrophils to the liver
capsule (21). However, whether capsule macrophages are
plastic and able to adapt to different environments has not yet
been addressed. Thus, these cells will not be discussed further in
this context. However, it is important to consider that these cells
may be mixed with the recruited macrophage populations
identified in many studies.
Acute Plasticity of Resident KCs
The highly phagocytic nature of KCs and the plethora of
complement and scavenging receptors on their surface (22, 26,
50) affords them the ability to rapidly identify and deal with
threats entering the liver via the bloodstream (7, 51, 52).
Moreover, through their interactions with LSECs, HSCs and
hepatocytes (36, 37, 41) they have the potential to play a
significant role in the orchestration of the hepatic response to
injury, inflammation and damage. They can sense damage
associated molecular patterns (DAMPs) released from dying or
injured liver cells, while also communicating with these cells to
instruct appropriate responses. Indeed, depletion of KCs from
mice using the Clec4f-DTR mouse model rapidly activates HSCs
and LSECs which produce TNFa and IL1b to recruit new
monocytes to the liver to replace the depleted KCs (36). The
presence of multiple subsets of macrophages and a lack of
markers to discriminate them makes interpretation of KC-
specific functions difficult for many studies. However, as
resident KCs are the main population of macrophages present
in the liver at the onset of injury, with recruited macrophages
typically only appearing after 48 hours (based on expression of
F4/80 and/or CD64 and lack of Ly6C expression) following their
differentiation frommonocytes, we can largely infer resident KC-
specific responses within this time window.
Many studies have reported the production of cytokines and
chemokines, as well as other factors such as complement factors
and prostaglandins by KCs initially upon encountering
inflammatory stimuli (7, 53–55). This suggests that resident
KCs do retain some plasticity and can mount responses to
inflammation and infection (Figure 2). In the setting of
pathogen-induced inflammation, this is coupled with KCs
encountering and engulfing pathogens or upon recognition of
soluble pathogen products. Depletion of TLR4 from myeloid
cells using Lysm-Cre mice significantly impaired phagocytosis
and bacterial clearance in the caecal ligation and puncture model
of polymicrobial sepsis (56), resulting in increased cytokine
production in the liver, although whether this was from KCs is
unclear. Suggesting the importance of resident KC clearance
capacity, depletion of hepatic phagocytes using clodronate
liposomes in mice infected with Borrelia burgdorferi, the
pathogen causing Lyme disease in humans, facilitated the
spread of bacteria resulting in increased bacterial burden in
bladder, heart, joints and spleen (57). However, as KC
depletion also activates the local niche cells (36), this altered
bacterial load may result from an altered local liver environment.
In sterile inflammation, the cue for this initial resident KCJune 2021 | Volume 12 | Article 690813
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dying cells such as hepatocytes (47). However, phagocytosis of
apoptotic bodies also plays a direct role in the initiation of
cytokine production from resident KCs (58). Fabp7 expression
by resident KCs has been associated with this process as Fabp7
KO mice demonstrated decreased phagocytosis of apoptotic cells
and decreased cytokine production in acute liver injury (59).
Similarly, clearance is suggested to be crucial in the context of
viral infection. Ablation of KCs during acute viral hepatitis
resulted in increased liver pathology and impaired apoptotic
cell removal suggesting resident KCs may have protective effects
(60). Although the potential caveats of KC depletion and niche
activation also apply here. Conversely, treating HBV DNA
carrying mice with an anti-PDL1 antibody reduced viral DNA
persistence and favoured CD8 effector T cell differentiation
indicating that the interaction between PD1 on T cells and
PDL1 expressed by KCs might inhibit effective virus clearance
(61). The production of cytokines, chemokines and other factors
from resident KCs early after sensing the inflammatory stimuli is
proposed to function in the recruitment of monocytes and
neutrophils to the injured liver [reviewed in (7)]. Indeed, while
resident KCs in the liver are specialized in sensing and capturing
the infectious agent in the tissue, it is suggested that recruitedFrontiers in Immunology | www.frontiersin.org 6monocyte-derived cells have potent microbicidal capacities (62,
63). Thus, this could explain the need for monocyte recruitment.
Similarly, in sterile injury, monocyte and neutrophil recruitment
is proposed to be important for repair. CCR2KO animals which
have severely reduced monocyte numbers do not display any
differences in terms of the extent of injury post APAP overdose,
however, significant delays in tissue repair were observed (64).
Furthermore, CCR2KO mice also have higher TNFa (mRNA)
levels in the liver 24h after APAP (65), although this may arise
from HSCs and LSECs attempting to recruit in monocytes (36).
Importantly, repair post APAP overdose is further exacerbated
when both resident KCs and monocytes/recruited macrophages
are missing from the liver (66), suggesting that resident KCs and/
or the niche cells could also directly contribute to repair. Apart
from their ability to mount inflammatory responses, resident
KCs have also been suggested to secrete tolerogenic mediators
such as IL10 (55, 67, 68). It has been shown in a murine model of
septic peritonitis that non-specific depletion of KCs by
clodronate liposomes leads to a significant reduction in
systemic and hepatic IL10 levels which was proposed to
be primarily KC-derived (67). This correlated with a higher
mortality, further suggesting that the initial resident KC response
to inflammatory stimuli may be crucial. Taken together, thisA B
FIGURE 2 | Plasticity vs Heterogeneity in the Inflamed Murine Liver. (A) KCs are the main macrophage population in the homeostatic liver. They are the sentinel cells
that can sense PAMPs from attacking pathogens and DAMPs from dying hepatocytes in the first stages of infection or liver tissue injury. KCs can also efferocytose
cellular debris from dead hepatocytes (47). Sensing of PAMPs and/or DAMPs activates KCs to produce chemokines and cytokines to call in monocytes and
neutrophils from circulation (7). Ly6Chi monocytes can differentiate locally depending on the cues from their microenvironment into recruited-temporary macrophages
or KCs. However, recruited KCs have not been observed in all settings (15). Alongside the recruited neutrophils, these recruited macrophage populations may
produce cytokines at the site, and help with cleaning up the pathogens/cellular debris. The loss of resident KCs has been reported in many inflammatory settings
(4, 15, 23–25, 32, 38, 39, 48) and may be caused by stress resulting from activation or from the increased metabolic load of ingested cellular debris. Recruited cells
such as recruited-temporary macrophages and neutrophils help to clean up the KC debris (49) and, in case of pathogen-induced inflammation, to capture/eliminate
pathogens and pathogen infected cells. Notably, neutrophils have limited lifespan in the tissues (49) and their debris is subsequently also cleaned up by hepatic
macrophages (33). With cellular debris removed, hepatocytes have space to replenish their numbers through proliferation. Resident KC numbers are also replenished
through their proliferation and/or engraftment of recruited KCs which subsequently acquire the resident KC phenotype (TIM4 expression). However, exactly how
similar resident and recruited KCs are when the latter are generated in an inflammatory environment remains to be seen. (B) If the inflammatory insult is not resolved
(e.g., in case of chronic infection, repeated injury or metabolic stress associated with increased lipid burden), the resolution phase is not reached and chronic
inflammation develops. Increased KC death activates the niche cells (LSECs, HSCs and hepatocytes) to call in Ly6Chi monocytes to replenish lost KCs (4, 23–25,
32). Continuous activation and/or tissue injury may lead to death of structural cells of the liver. The recruitment of cells from circulation is continuous. Recruited
monocytes differentiate locally into KCs and/or recruited-temporary macrophages, depending on the cues from their microenvironment. For example, activated HSCs
produce and deposit increased amounts of collagen, which leads to liver fibrosis. Monocytes recruited to fibrotic zones harbouring large numbers of activated stellate
cells/fibroblasts differentiate into recruited-temporary macrophages expressing CD9+TREM2+ called hepatic LAMs/SAMs (4, 30, 32). As with acute injury/infection/
inflammation, recruited KCs can acquire the TIM4-expression with time (4, 23) and the cycle continues. As in acute inflammation, how similar or distinct recruited and
resident KCs are remains a matter of debate.June 2021 | Volume 12 | Article 690813
Zwicker et al. Hepatic Macrophage Heterogeneity and Plasticityability of resident KCs to respond to the changes in the local
environment suggests that these cells do retain some plasticity
despite having resided in the homeostatic liver for prolonged
time periods before injury/infection.
While this resident KC response is relatively well
documented, whether this response is protective or detrimental
remains unclear. Possibly suggestive of a protective role for these
cells, previous studies have shown increased serum AST/ALT
levels indicating increased damage when resident KCs are
depleted by clodronate liposomes 48 hours prior to
administration of an APAP overdose (69, 70). Similarly, injury
post APAP overdose (8 and 24 hours) is exacerbated in mice
deficient in MerTK which harbour less KC at steady state (33).
However, whether this worsened injury is linked to resident KC
cytokine/chemokine production remains unclear. In one study,
clodronate liposome treatment 48 hours prior to administration
of APAP reduced TNFa, IL10, IL6, IL18BP and complement 1q
mRNA levels in liver tissue 8 hours post overdose (69), however
it should be noted that IL6, IL10 and C1q were already reduced
prior to administration of APAP due to the depletion of resident
KCs, while the baseline effects on TNFa were not assessed (69).
The other study however, following the same treatment regime
but administering higher concentrations of APAP, observed
increased plasma IL6 and decreased IL1b levels 24 and 48
hours post overdose, while no effects were seen in plasma
TNFa and IL10 levels (70). As clodronate liposome
administration can also affect monocyte levels, either directly
through their depletion (71) or indirectly by inducing monocyte
recruitment to repopulate depleted macrophages, this is likely a
confounding factor in this analysis, especially regarding cytokine
production, as monocytes recruited to the liver may also produce
these factors. Given that this enhanced monocyte recruitment
upon resident KC depletion is also observed in KC-specific
depletion models such as the Clec4f-DTR model (22, 36), we
will need a more refined approach to assessing the function of
KCs in inflammation rather than depletion. This is especially
true, in light of the temporal niche activation observed post KC-
depletion (36). The Clec4f-Cre model (50) should allow for a
more specific interrogation of resident KC function if utilised
prior to the development of any recruited KCs in inflammatory
settings, alternatively an inducible Clec4f-Cre model would allow
KC activation to be studied more accurately. In addition, it will
also be necessary to consider heterogeneity in the resident KC
response. Recently, scRNA-seq analysis identified activated
resident KCs 20 hours after APAP or Thioacetamide (TAA)
administration. Fitting with the above, these activated resident
KCs were characterised by increased chemokine expression (72).
Surprisingly, not all KCs in treated livers were activated, rather
these cells represented a proportion of the total resident KC pool
(72). The precise factors influencing this heterogeneity, including
activation of the local niche, remain to be investigated.
Lack of Long-Term Resident KC Plasticity
in Acute Injury
While there appears to be evidence for plasticity early in the
inflammation cascade, allowing resident KCs to respond andFrontiers in Immunology | www.frontiersin.org 7call in the required back-up, there is emerging evidence that
this response may be tightly regulated in time. For example,
while a subset of activated KCs was identified 20 hours after
APAP overdose (72), bulk RNA sequencing data of KCs 72
hours after APAP overdose, a timepoint when there are
significant numbers of recruited-temporary macrophages
present in the liver, did not reveal any overt changes in the
KC transcriptional profile (15). This could suggest that in this
setting of sterile inflammation, KCs do not exhibit long-term
plasticity. Alternatively, as scRNA-seq analysis demonstrated
that it was only a subset of resident KCs that were activated at
the early timepoint post APAP overdose (72), it is possible that
this subset may have been overlooked in the bulk RNA
sequencing data. Another possibility is that activated resident
KCs may die shortly after their activation (Figure 2). This
would fit with the reported reduction in KCs in sterile and
pathogen induced inflammation (4, 15, 23–25, 32, 39, 48).
Indeed, necroptosis of KCs in the early phase of infection
such as seen with Listeria monocytogenes (Lm) is proposed to
be an altruistic mechanism to attract cells with potent
microbicidal functions (62). This mechanism appears to be
conserved among macrophages in different tissues (3, 43, 73,
74) and thus might represent an additional way to recruit cells
which are specialized in eliminating microbes such as
neutrophils and monocytes. Thus, perhaps by 72 hours post
APAP overdose the activated resident KCs are lost and hence
the remaining population are those not activated initially. It is
also important to note that due to the acute nature of the APAP
overdose model, 72 hours post overdose the liver has already
undergone considerable repair, thus the limited response of the
KCs at this timepoint may be due to the absence of further
hepatocyte death and associated signals to which a response
from KCs is warranted. Considering this, it will be important to
assess the temporal nature of the resident KC response
fol lowing APAP overdose by profi l ing the cel ls at
intermediate timepoints between 20 and 72 hours. If activated
resident KCs are lost following APAP overdose at later
timepoints, this opens up many questions including how
quickly do the activated resident KCs die? Is their death
necessary, for example is it important for priming the
incoming monocytes? Moreover, what signals promote their
death? Uptake of erythrocytes has been shown to lead to
resident KC death (40), thus does efferocytosis/phagocytosis
play a role here? Or could it be that an activated resident KC is
no longer adapted to its environment and hence cannot be
maintained? This assumption would demonstrate a lack of
plasticity in these cells. Similarly, if resident KC plasticity is
limited, perhaps it is the stress associated with this early
activation that results in their death? Answering these
questions will be crucial for our understanding of this
response and how it can be manipulated for therapeutic benefit.
Lack of Long-Term Resident KC Plasticity
in Chronic Injury
While understanding the longevity of the resident KC
response to inflammatory stimuli is limited in models of acuteJune 2021 | Volume 12 | Article 690813
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heterogeneity in the setting of more chronic inflammation
such as MAFLD and non-alcoholic steatohepatitis (NASH)
have shed further light on this. Fitting with a limited
activation of resident KCs, we recently found that even after
prolonged exposure to western diet (24-36 weeks) and
establishment of MAFLD and NASH, resident TIM4+ KCs
did not dramatically alter their transcriptional profile,
particularly in relation to expression of prototypical immune
activation genes such as pro-inflammatory cytokines (4). This
was consistent with another study which did not see significant
activation of total human hepatic macrophages from lean and
obese patients or in total murine hepatic macrophages fed a
high fat diet for 3, 9 or 12 weeks (14). Notably, in this study, an
increase in Tnf was reported after 12 weeks of diet but here the
macrophage population was not split into distinct subsets and
this timepoint also correlated with the infiltration of recruited
macrophages. Thus, this increase was attributed to the recruited
macrophages (14). Conversely, however, other studies have
reported changes in the resident KC transcriptome in murine
models of NASH. While a first study likely mixed resident KCs
and recruited-temporary macrophages (LAMs) leading to the
conclusion that KCs were activated in NASH (75), another
recent study where NASH was induced in mice by feeding a
methionine and choline deficient diet (MCD diet), did report
increased expression of pro-inflammatory genes in resident
KCs after 6 weeks of feeding (23). Notably, here the authors
did distinguish between KCs resident in the liver before and
after NASH induction using BM chimeras demonstrating that
those present before inflammation can be activated. Whether
this is true of the whole population or a subset of resident KCs
was not examined (23). Another recent study also found
significant changes in the resident KC transcriptome upon
feeding a NASH-inducing diet for up to 30 weeks (24).
However, here the majority of these changes were associated
with the loss of KC identity driven by altered LXR signalling
(24), as observed when LXRa expression is removed from
homeostatic KCs (50). This loss of KC identity may result
from changes to the local microenvironment altering the
signals given to the KC population (24). Another study found
resident KCs to express reduced levels of Calprotectin encoded
by S100a8/S100a9 following 16 weeks of feeding a Western diet
(76). These discrepancies regarding the resident KC response in
MAFLD and NASH between studies highlight that we do not
yet fully understand the mechanisms governing this. One
possibility is that the diet used to induce NASH may alter the
resident KC response as all studies utilised different diets for
different periods of time. Nevertheless, this would further
suggest some plasticity of the resident KCs, albeit dependent
on the signals received.
Despite the differences in the degree of resident KC
activation reported, all these NASH studies observed a
reduction in the proportion and/or number of resident KC
populations (4, 23–25, 32). This death and loss of resident
KCs in NASH would fit with the concept that upon activation
KCs can no longer self-maintain and are lost from the tissue asFrontiers in Immunology | www.frontiersin.org 8discussed above. This loss may also help to explain the
heterogeneous response of resident KCs across models. For
example, it is possible that activated resident KCs are not fit
enough to survive the lengthy digestion processes used in some
studies used to liberate these cells (4). The advent of techniques
for profiling these cells without the need for tissue digestion
such as snRNA-seq and spatial transcriptomics approaches will
enable this question to be addressed in the near future and is
something we are currently investigating. Alternatively, as
suggested by the Glass lab, this loss of resident KCs may be
irrespective of activation state but rather due to a loss of KC
identity (24). Whether related to activation or identity, this loss
of resident KCs suggests that despite maintaining some
plasticity to respond initially, these cells are not plastic
enough to adapt to the inflammatory environment long-term.
Fitting with this, it would be very interesting to profile the
resident KCs when the diets are first switched to assess if the
change in diet has any effects on the resident KC population not
observed after prolonged feeding.
A Possible Role for the Microbiota in
KC Plasticity
The specific microbiota composition of the mouse colonies in the
different animal houses may also play a role in the distinct
responses of resident KCs across models. Indeed, as KCs are
preferentially localized in peri-portal zones, where they can more
effectively capture and fight microbes coming from the intestine
via the portal vein (37), differences in microbiota could explain
these differential KC responses. Such modulation of the extent of
liver injury by the microbiota has been reported in the APAP
overdose model, where injury was attenuated in germ-free (GF)
mice, or in SPF mice treated with antibiotics (72). The lack of
microbiota inhibited the MYC-activated transcriptional program
in various hepatic cell populations, leading to lesser injury (72).
Fitting with a potential role for the microbiota, gut microbiota
dysbiosis due to chronic use of antibiotics or proton pump
inhibitors was implicated in higher susceptibility to acute liver
failure after APAP overdose in humans, which was recapitulated
in dysbiotic Nlrp6-/- mice and in WT mice that were transferred
faecal microbiota from Nlrp6-/- mice (77). The use of antibiotics
removed the difference in liver injury between WT and Nlrp6-/-
mice (77), suggesting that a specific microbial species present in
the Nlrp6-/- mice might have a negative effect on liver injury after
APAP overdose. This effect could be mediated through altered
microbial metabolites. For example, one such metabolite, 1-
phenyl-1,2-propanedione has been shown to aggravate APAP-
induced liver injury by modulating glutathione levels in the liver
(78). Another study suggesting a role for commensal microbiota
in shaping hepatic macrophage responses, has demonstrated that
the absence of commensal microbes in GF mice resulted in an
impaired ability of KCs to clear Staphylococcus aureus from
circulation resulting in increased systemic pathogen load and
higher mortality of these mice compared with mice kept in SPF
conditions (79). In addition to regulating KC function, the
microbiota has also been shown to affect the development of
capsule macrophages. While sparse during neonatalJune 2021 | Volume 12 | Article 690813
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significantly after weaning and is then maintained throughout
adult life (21). However, whether the microbiota influences
capsule macrophage plasticity in the liver remains to
be investigated.
Plasticity of Recruited KCs – A Role for
the Local Environment?
As discussed above, as many studies have not yet accurately
distinguished between hepatic macrophage populations, it is not
possible yet to know if recruited monocytes always give rise to
KCs in inflammatory settings or how plastic these cells may
therefore be. Here we will discuss what is currently known or can
be extrapolated from existing data. A key question when
discussing this is how similar are these recruited KCs to their
resident counterparts? Our own studies investigating newly
recruited KCs following resident KC depletion under
homeostatic conditions using the Clec4f-DTR mouse, did not
identify any long-term differences in terms of the transcriptome
or phagocytic capacity of the new recruits compared with
resident KCs (22). We did not however, investigate any
potential epigenetic differences nor did we probe their
functionality in different inflammation models, thus we cannot
rule out the possibility that recruited KCs may behave differently
to resident KCs in some settings (Figure 2). Indeed, using BM
chimeric mice, Beattie et al., have demonstrated that in mice
treated with heat-killed pathogenic bacteria congenically-marked
recruited KCs, generated following whole-body irradiation
(resulting in KC depletion), exhibited an increased phagocytic
potential compared to resident KCs (26). However, if resident
KC function may have been affected by the irradiation is
unknown. Conversely, a study by David et al., which used
clodronate liposome to non-specifically deplete resident KCs
has suggested that monocytes and recruited KCs have a
reduced ability to phagocytose intravenously transferred non-
pathogenic E. coli as evidenced by increased bacteria counts in
the blood (80). Whether these discrepancies are due to
differences in the system used to induce the differentiation of
recruited monocytes into KCs or due to strain-specific features
and/or viability of the different bacteria used remains to be
determined. These studies could suggest that the specific
setting in which KCs are generated may alter their behaviour.
While at first sight this may suggest some plasticity, we would
question if this could be considered as recruited KC plasticity or
rather plasticity within the infiltrating monocytes. The effect of
the KC-ablation protocol on the local microenvironment is also
worth considering in these studies, as this may also have an
impact on the fate of the infiltrating cells. Fitting with this, a
recent study by Louwe and colleagues has demonstrated that
the local environment coupled with the presence of any
remaining resident macrophages appears to dictate the
phenotype of recruited macrophages in the peritoneal cavity
(12). In different inflammatory settings recruited peritoneal
macrophages were all able to persist long-term, however,
these were maintained in an immature transitory state when
resident macrophages were also present but a mature resident-Frontiers in Immunology | www.frontiersin.org 9like state when the original resident macrophages were fully
depleted (12).
Plasticity of Recruited KCs – NASH
Differences between recruited and resident KCs have also
recently been reported in the context of NASH. While
recruited KCs have been described in a number of different
studies irrespective of the precise dietary model used to induce
NASH, how similar these are to their resident counterparts
appears to be diet-specific (4, 23, 24). Fitting with the relative
quiescence of the resident KC population observed after feeding
a western diet for up to 36 weeks compared with controls, we did
not observe significant differences in the transcriptional profiles
of resident and recruited KCs in this model (4). Similarly, the
study from the Glass lab did not observe significant differences
between resident and recruited KCs in NASH (24). Conversely,
the study from the Gautier lab, the only one to truly distinguish
between recruited and resident KCs using BM chimeras rather
than relying on the temporal lack of TIM4 expression, identified
differences between resident and recruited KCs. Here, recruited
KCs in the MCD diet model of NASH were more pro-
inflammatory and less able to store triglycerides than their
resident counterparts (23). Notably, increasing the recruited
KC population in this model also led to exacerbated disease
(23), although whether this is directly linked to the presence of
recruited KCs or a result of an activated niche upon depletion of
resident KCs to induce KC recruitment remains to be dissected.
Interestingly, upon return to normal chow following feeding the
MCD diet, recruited KCs were found to persist for at least 12
weeks (23). A previous study investigating recruited KC
persistence in the MCD model of NASH using TIM4
expression to discriminate between resident and recruited KCs,
found that TIM4- recruited KCs were reduced following return
to normal chow (25). Thus, this likely suggests that recruited KC
persistence following recovery from NASH is associated with
acquisition of TIM4 expression. This would also fit with BM
chimera studies demonstrating no additional input from the BM
to the hepatic macrophage pool post recovery, while a low level
of chimerism was maintained in TIM4+ KCs (25). The key
question now, is whether these persistent recruited KCs
maintain their pro-inflammatory phenotype or if with time in
the recovered liver they can alter their phenotype in line with
homeostatic resident KCs as has been observed for monocyte-
derived alveolar macrophages (3). Similarly, it will be intriguing
to determine if the remaining resident KCs in this MCD-model
also maintain their altered profile or revert to their homeostatic
profile during recovery. Understanding this from both a
transcriptomic and epigenetic viewpoint will provide valuable
insight into the question of resident and recruited KC plasticity.
Plasticity of Recruited KCs – Pathogen
Induced Inflammation
What about recruited KCs in pathogen-induced inflammation?
Infection with the facultative intracellular pathogen Lm has been
shown to lead to a contraction of the resident KC pool followed
by the recruitment of monocytes and the development ofJune 2021 | Volume 12 | Article 690813
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expression of F4/80, Ly6C and CD11b the authors of this study
discriminate between resident KCs (F4/80+ CD11blo Ly6Clo),
recruited macrophages (F4/80+ CD11bhi Ly6Cint) and monocytes
(F4/80+ CD11bint Ly6Chi) and proposed that both the recruited
macrophages and resident KCs, proliferate in response to Lm
infection in order to repopulate the available niches in the liver
(48) (Figure 2). However, based on these markers, the precise
fate of the recruited macrophages in this setting is unclear.
Firstly, the definition as Ly6C intermediate raises some
questions regarding their designation as macrophages which
typically lack Ly6C expression. Next, it is unclear, if these
resemble recruited-temporary macrophages or recruited KCs?
In the setting of erythrocyte clearance, recruited macrophages
were found to have the same F4/80 and CD11b expression profile
as resident KCs (40), but even then, without KC-specific markers
it is difficult to determine the exact nature of these cells. If the
macrophages recruited in Lm infection become recruited KCs
are these retained in the tissue post pathogen clearance or are
these also lost being replaced by proliferating resident KCs?
Notably, while Lm induced a type 1-dominated response
characterized by increased Ifng transcripts in Ly6Chi
monocytes and recruited macrophages early after infection,
genes associated with a tissue repair profile including Arg1 and
Chil3 were upregulated in these populations during the
resolution phase of the infection (48). This could suggest that
these recruited monocytes and macrophages unlike the resident
KCs are plastic being able to alter their phenotype as required by
the tissue, starting out as an inflammatory monocyte and
gradually differentiating into a repair macrophage.
Alternatively, it could suggest that there are two waves of
monocyte recruitment and macrophage differentiation and this
remains to be investigated (Figure 2). Similarly, F4/80+ CD11blo
Ly6Clo cells defined in this study as resident KCs showed
increased Chil3 transcript levels at later stages of the infection
(day 3) (48), suggesting the resident KCs may have additional
plasticity in this model. However, another likely option is that at
this timepoint recruited macrophages (KCs and/or recruited-
temporary macrophages) can be found within the cells defined
here as resident KCs. In this setting, one hypothesis could be that
the Chil3 expression is restricted to recruited macrophages
infiltrating this gate. With this possibility in mind, it would be
interesting to evaluate the nature of the recruited macrophage
population and determine how long these populations and the
Chil3 signature persists post infection.
Consistent with Lm infection, infection with Vaccina virus
has been shown to lead to an almost complete loss of resident
KCs which was also compensated by the recruitment of
monocytes (81). A similar depletion of resident KCs was also
observed with murine cytomegalovirus infection (81) further
highlighting the conserved nature of this response. Using
CLEC4F expression as a marker of bona fide KCs, Borst et al.
were able to demonstrate that the recruited monocytes in this
instance subsequently differentiated into KCs (81) (Figure 2).
Notably, in vaccinia infection, recruited KC development was
regulated through type I IFN and IFNAR signalling. In aFrontiers in Immunology | www.frontiersin.org 10competitive BM chimera setting, IFNAR KO monocytes more
efficiently engrafted and differentiated into recruited KCs than
WT counterparts (81). Loss of IFNAR signalling also altered the
recruited KC phenotype, increasing expression Arg1, Ym1 and
Nos2 (81). This nicely suggests that recruited KCs do display
some plasticity as they respond differently depending on the cues
they receive from the local environment. Alternatively, as IFNAR
expression was eliminated from either all cells (full body KO) or
LysM expressing cells, this altered phenotype of recruited KCs
may instead be a feature of monocyte and not recruited
KC plasticity.
During the reproductive cycle of the blood fluke Schistosoma
mansoni in vertebrate hosts some eggs are deposited in the liver
leading to a type 2-driven granulomatous reaction (82, 83).
During this process IL4/IL13 alternatively activated hepatic
macrophages accumulate around granulomas promoting tissue
repair and the formation of fibrotic tissue (84). Rolot et al. have
recently demonstrated that infection with S. mansoni resulted in
a strong reduction of the resident KC pool, accompanied by an
increase in CD64+F4/80+CD11bhi recruited macrophages (39).
This increase in CD11bhi macrophages was independent of
IL4Ra (39), which is in contrast to serous cavity macrophages
(resident and recruited) which exhibit strong, IL4-dependent
proliferation in response to nematode infection (85, 86).
Through the use of shielded BM chimeras, these CD11bhi
macrophages were demonstrated to be of monocyte origin
(39). This observation is in line with previous reports
demonstrating that increased numbers of monocyte-derived
macrophages can be found in the liver after S. mansoni
infection (87, 88). While like in the other infection models, it
is tempting to speculate that these may represent recruited KCs,
as KC-identity gene expression was not assessed, the specific
nature of these cells remains to be determined. Notably, these
cells were found to proliferate suggesting they are capable of self-
renewal (Figure 2), although it is not clear if there is also
continual replenishment from monocytes over the course of
the infection (10 weeks) (39). In comparison, the remaining
few resident KCs showed limited proliferative capacity
potentially explaining their loss over the course of the infection
(39). In terms of the phenotype, the recruited macrophages, in
addition to their increased expression of CD11b, also expressed
Arg1, Chil3, Retlna and Nos2 compared with resident KCs (39).
This phenotype was dependent on IL4Ra signalling, although
loss of IL4Ra from myeloid cells did not alter host survival post
infection (39). This limited response of the resident KCs
compared with the recruited macrophages again highlights the
plasticity of incoming monocytes and/or differentiating
macrophages compared with resident KCs.
Taken together, while we do not yet have all the information,
recruited KCs appear to be capable of editing their phenotype
based on their local environment. However, whether this
represents recruited KC or monocyte plasticity remains to be
directly tested. Moreover, whether these cells are really more
plastic than resident KCs remains to be formally examined
although evidence discussed above would suggest this is the
case. It would be interesting to examine how similar or distinctJune 2021 | Volume 12 | Article 690813
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determine exactly how plastic these cells are. With the recent
boom in scRNA-seq data, such a comparison may be possible
relatively soon. Moreover, it will be important to determine the
fate and plasticity of these cells upon elimination of the
inflammatory stimuli. Do these cells always persist and if so,
how similar are their transcriptomic and epigenetic profiles
during and after resolution of inflammation? Finally, it will
also be crucial to assess how efficiently these recruited KCs,
generated in the course of inflammation can respond to
additional stimuli.
Recruited-Temporary Macrophages-NASH
Rather than differentiating into KCs, monocytes recruited to the
inflamed liver may also take on an alternative fate and
differentiate into recruited-temporary macrophages (Figure 2).
The factors controlling this decision remain to be determined,
however, as is the case for the KCs, this is likely decided by the
local micro-environment into which the monocytes are
recruited, due to local cell-cell interactions or possibly local
metabolite concentrations. For example, in the setting of
MAFLD and NASH, monocytes can differentiate into either
KCs or Lipid-associated macrophages (LAMs; Figure 2) (4,
32). LAMs, and their putative precursors, called c-LAMs,
preferentially localise in zones of fibrosis (Figure 2), while
recruited KCs were found to be located in similar zones to
their resident counterparts (4, 32). This localisation of LAMs
suggests that the local signals provided by fibrotic stellate cells
and other activated fibroblasts may contribute to the
differentiation of these cells, although the precise signals
involved are currently unknown (Figure 2). In addition to
signals deriving from the activated fibroblasts in NASH, signals
from dead/dying hepatocytes may also be involved in instructing
the LAM/c-LAM phenotype as c-LAMs have been shown to be
specifically enriched in hepatic crown-like structures (hCLS) (32)
which are specific histological formations consisting of
macrophages surrounding lipid-rich apoptotic hepatocytes
characteristic of NASH (89). This is not the first description of
hCLS-macrophages in the fatty liver, as a population of CD11c+
macrophages have also been described around these structures in
the MC4R KO model of NASH (90). There, they were proposed
to arise from resident KCs, however given the expression of Itgax
(encoding CD11c) by LAMs/c-LAMs and lack of expression by
KCs (32), it is tempting to speculate that these also represent
recruited-temporary macrophages. However, as the two studies
use distinct models of NASH, this also need further investigation.
Finally, local lipid exposure could also play a role in driving the
LAM phenotype, since a similar population of recruited-
temporary macrophages are also observed in obese adipose
tissue (91).
In fibrotic and cirrhotic human livers, a population of
recruited macrophages called scar-associated macrophages or
SAMs have been described in fibrotic zones (30). Human SAMs
and murine LAMs display very similar phenotypes and
transcriptional signatures (4) highlighting the potential clinical
relevance of recruited-temporary macrophages. Notably, theFrontiers in Immunology | www.frontiersin.org 11temporary nature of these macrophages has not been
demonstrated in mice or humans as no studies have yet
investigated their persistence post recovery. However, we
would hypothesize that if the fibrotic niche of these cells would
be lost, then the LAMs would also fail to thrive. An alternative
hypothesis could be that upon resolution, LAMs would alter their
phenotype to become KCs. This outcome would depend on
exactly how plastic these cells are following their differentiation
and existence in the fatty liver and hence investigating this
represents an interesting goal. Another outstanding question
regarding these cells relates to their origins. Is it the same
monocyte precursor that gives rise to both KCs and LAMs/
SAMs or are there subsets of monocytes in the BM, possibly
induced by the systemic inflammation that have a restricted
differentiation potential? A population of pro-fibrotic monocytes
has been described in the setting of lung fibrosis that are critical
for the development of fibrosis (92) and thus investigating if
hepatic macrophage heterogeneity stems from monocyte
heterogeneity represents an interesting question for the future.
Recruited-Temporary Macrophages-Acute
Sterile Injury
What about other models of inflammation, are recruited-temporary
macrophages generated and how distinct are these cells across
inflammatory settings? Following APAP overdose, a population of
recruited-temporary macrophages have been described. These cells
differentiate from monocytes between 48 and 72 hours post
overdose and are lost from the tissue upon resolution of
inflammation between 5 and 7 days post the overdose (15).
Notably, no recruited KCs have been reported following APAP
overdose. This is despite the fact that a reduction in the resident KC
pool (proportion and number) has been reported in this model
suggesting the niche is available (15, 38). The precise reasons for the
lack of recruited KCs thus remains to be investigated, however,
given the strict zonation of the injury around the central vein, a zone
usually largely devoid of KCs it is possible that the niche in that
location is not permissive of KC generation. To assess this, it will be
important to investigate the location of recruited monocytes and the
signals present in their local environment skewing monocyte
differentiation. An examination of the recruited-temporary
macrophages 72 hours post APAP overdose demonstrated that
they have a very distinct transcriptional profile to KCs with 135
differentially expressed genes (DEGs). Note only 2 DEGs were
described between homeostatic and APAP KCs at this timepoint
(15). In addition to expressing genes associated with a monocyte
origin including Ccr2 and Cx3cr1, APAP recruited-temporary
macrophages also expressed many restorative genes including
Mmp8, 14 and 19 and extracellular matrix structural components
including Thbs1, Fn1 and Vcan, suggesting these cells may play
distinct roles to KCs in repair. However, as many of these genes
were shared with Ly6Chi monocytes the specific roles of these cells
remain to be seen. Similar to the mouse, human APAP overdose is
also characterised by an increase in macrophages (33). These were
found to express MerTK and CD163 and were localised around the
central vein, where injury occurs (33). As relatively few MerTK+
macrophages were found in the liver outside of these zones (33),June 2021 | Volume 12 | Article 690813
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macrophage equivalents (Figure 1B). In both mouse and human,
how similar these APAP recruited-temporary macrophages are to
those in other inflammatory settings has not yet been investigated.
In NASH, the recruited-temporary macrophages were termed
LAMs due to their similarity with LAMs described in obese
adipose tissue (91). As APAP overdose is not associated with
increased dietary lipid content and obesity, it is tempting to
speculate that the recruited-temporary macrophages here will
have a distinct phenotype to LAMs. However, as recruited-
temporary macrophages likely function to clear up cellular debris
including lipid-material (Figure 2), perhaps these cells will have a
similar profile across models.
Recruited-Temporary Macrophages-
Pathogen-Induced Inflammation
In the context of infection, the nature of recruited-temporary
macrophages is less clear. As described above, infection is
associated with loss of resident KCs and recruitment of
monocytes which differentiate into macrophages. For the most
part, whether these recruited macrophages represent KCs or
recruited-temporary macrophages remains to be investigated
(Figure 2). Along these lines it is also possible that both
recruited-temporary macrophages and recruited KCs may be
present in these settings, however, to date as these cells have not
been distinguished it is impossible to speculate on how plastic
and distinct these populations may be. Understanding this will
be a key goal for the field in the coming years.
Recruited-Temporary Macrophages: The
Cause of the Perceived Plasticity?
Overall, given the relative paucity of studies discriminating
recruited macrophage populations in different inflammatory
settings, it is more difficult to assess the responses and
associated plasticity of these cells and hence further studies are
needed to dissect this. It is, however, worth mentioning that in
the context of MAFLD and NASH, the LAMs displayed distinct
transcriptional and lipidomic profiles from resident and
recruited KCs suggesting that these cells are quite distinct from
KCs (4, 32). Similarly, recruited-temporary macrophages in
APAP are quite distinct from KCs (15). However, whether
these cells are more plastic than KCs is unclear. Moreover, any
plasticity in this population could reflect the limited time spent in
the tissue and the high plasticity of the monocytes giving rise to
these cells. If recruited-temporary macrophages were truly more
plastic after their development, one might argue that these cells
would not be ‘temporary’ and lost from the tissue upon
resolution of inflammation. Rather one might expect that these
cells would be able to adjust to the non-inflamed environment
enabling them to be maintained in the liver upon recovery.
Notably, in the few cases where recovery has been assessed to
date such as following APAP overdose, this does not seem to be
the case. Of course, it could also be argued that this lack of
residence of the recruited-temporary macrophages is not
reflective of a lack of plasticity but rather informative of a lack
of an available niche in which they can be maintained (20).Frontiers in Immunology | www.frontiersin.org 12To test this, KCs could be specifically depleted in the initial
phases of resolution prior to loss of (CLEC4F-) recruited-
temporary macrophages. If truly plastic, we would hypothesise
that the recruited-temporary macrophages may then alter their
phenotype to become KCs and fill at least some of the available
KC niche. If not plastic, a new wave of monocytes would be
expected to engraft and repopulate the empty KC niche.
Although seemingly theoretical, understanding the plasticity of
recruited macrophages may be instrumental in our ability to
target these cells for therapeutic purposes. The presence of
recruited macrophages across inflammatory models, suggests
that these could be a useful population to target clinically.
Developing our understanding of these cells in the context of
liver inflammation thus represents an important aim for
the future.CONCLUDING REMARKS AND FUTURE
PERSPECTIVES
While in homeostatic conditions resident KCs and capsule
macrophages can be identified in the liver, in recent years
numerous studies have provided compelling evidence that in
inflammatory conditions there is considerably more
heterogeneity among hepatic macrophages. Depending on the
nature of the inflammatory stimulus and the timepoint during/
after the insult recruited KCs and/or recruited-temporary
macrophages can be identified in the liver in addition to the
aforementioned populations. As this heterogeneity leads us to
question the assumption that KCs are highly plastic
macrophages, here we have discussed what is currently known
regarding the different responses of the distinct hepatic
macrophage subsets. It is clear from this discussion, that we
still have a long way to go before we understand this fully. While
we have started to gather some evidence, which clearly suggests
that recruitment of macrophages in inflammation plays a
significant role in explaining the perceived plasticity of the
global hepatic macrophage population, a number of questions
remain. Specifically, is the loss of KCs in inflammation caused by
a lack of plasticity or rather is it an altruistic mechanism to
recruit cells with specialized functions? Are resident KCs capable
of responding long-term in the context of chronic inflammation,
or is this response dampened upon recruitment of monocyte-
derived macrophages? With regards to the recruited
macrophages, while these indeed appear to be more plastic
than the resident KCs, questions remain regarding whether
this increased plasticity is observed in the monocyte or
differentiated macrophage and if it is linked to ontogeny or the
time they spend in the tissue? Moreover, whether this increased
plasticity is observed following resolution of inflammation
remains to be tested in the liver. Finally, it will also be crucial
to better understand the signals provided by the liver niche and
their impact on the development of the different macrophage
populations and the maintenance or loss of their plasticity. We
anticipate that in the coming years the increased availability of
classical and spatial transcriptomic technologies and theJune 2021 | Volume 12 | Article 690813
Zwicker et al. Hepatic Macrophage Heterogeneity and Plasticitydevelopment of specific tools allowing the distinct macrophage
populations to be fate-mapped and/or targeted will considerably
advance our understanding of macrophage heterogeneity, functions
and plasticity in the liver. Using these tools and technologies to gain
a better understanding of hepatic macrophage biology in mice and
humans will allow to develop new and/or refine existing strategies to
target these cells therapeutically.AUTHOR CONTRIBUTIONS
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Maintenance of the Macrophage Niche. Immunity (2020) 52:434–51. doi:
10.1016/j.immuni.2020.02.015
43. Liu Z, Gu Y, Chakarov S, Bleriot C, Kwok I, Chen X, et al. Fate Mapping Via
Ms4a3-Expression History Traces Monocyte-Derived Cells. Cell (2019)
178:1509–25.e19. doi: 10.1016/j.cell.2019.08.009
44. Dutertre C-A, Becht E, Irac SE, Khalilnezhad A, Narang V, Khalilnezhad S,
et al. Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-
Defining Markers and Identifies Circulating Inflammatory Dendritic Cells.
Immunity (2019) 51:573–89.e8. doi: 10.1016/j.immuni.2019.08.008
45. See P, Dutertre C-A, Chen J, Günther P, McGovern N, Irac SE, et al. Mapping
the Human DC Lineage Through the Integration of High-Dimensional
Techniques. Science (New York NY) (2017) 356:eaag3009. doi: 10.1126/
science.aag3009
46. Villani A-C, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al.
Single-Cell RNA-Seq Reveals New Types of Human Blood Dendritic Cells,
Monocytes, and Progenitors. Science (New York NY) (2017) 356:eaah4573.
doi: 10.1126/science.aah4573
47. Gaskell H, Ge X, Nieto N. High-Mobility Group Box-1 and Liver Disease.
Hepatol Commun (2018) 2:1005–20. doi: 10.1002/hep4.1223
48. Blériot C, Dupuis T, Jouvion G, Eberl G, Disson O, Lecuit M. Liver-Resident
Macrophage Necroptosis Orchestrates Type 1 Microbicidal Inflammation andFrontiers in Immunology | www.frontiersin.org 14type-2-mediated Tissue Repair During Bacterial Infection. Immunity (2015)
42:145–58. doi: 10.1016/j.immuni.2014.12.020
49. Ballesteros I, Rubio-Ponce A, Genua M, Lusito E, Kwok I, Fernández-Calvo G,
et al. Co-Option of Neutrophil Fates by Tissue Environments. Cell (2020)
183:1282–97.e18. doi: 10.1016/j.cell.2020.10.003
50. Scott CL, T’Jonck W, Martens L, Todorov H, Sichien D, Soen B, et al. The
Transcription Factor ZEB2 Is Required to Maintain the Tissue-Specific
Identities of Macrophages. Immunity (2018) 49(2):312–25.e5. doi: 10.1016/
j.immuni.2018.07.004
51. Crispe IN. The Liver as a Lymphoid Organ. Annu Rev Immunol (2009)
27:147–63. doi: 10.1146/annurev.immunol.021908.132629
52. Jenne CN, Kubes P. Immune Surveillance by the Liver. Nat Immunol (2013)
14:996–1006. doi: 10.1038/ni.2691
53. Yan J, Li S, Li S. The Role of the Liver in Sepsis. Int Rev Immunol (2014)
33:498–510. doi: 10.3109/08830185.2014.889129
54. Woolbright BL, Jaeschke H. The Impact of Sterile Inflammation in Acute
Liver Injury. J Clin Transl Res (2017) 3(S1):170–88. doi: 10.18053/
jctres.03.2017S1.003
55. Knolle P, Schlaak J, Uhrig A, Kempf P, H. M. zum Büschenfelde K, Gerken G.
Human Kupffer Cells Secrete IL-10 in Response to Lipopolysaccharide (LPS)
Challenge. J Hepatol (1995) 22:226–9. doi: 10.1016/0168-8278(95)80433-1
56. Deng M, Scott MJ, Loughran P, Gibson G, Sodhi C, Watkins S, et al.
Lipopolysaccharide Clearance, Bacterial Clearance, and Systemic
Inflammatory Responses Are Regulated by Cell Type–Specific Functions of
TLR4 During Sepsis. J Immunol (2013) 190:5152–60. doi: 10.4049/
jimmunol.1300496
57. Lee W-Y, Moriarty TJ, Wong CHY, Zhou H, Strieter RM, van Rooijen N, et al.
An Intravascular Immune Response to Borrelia Burgdorferi Involves Kupffer
Cells and iNKT Cells. Nat Immunol (2010) 11:295–302. doi: 10.1038/ni.1855
58. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF,
et al. Kupffer Cell Engulfment of Apoptotic Bodies Stimulates Death Ligand
and Cytokine Expression. Hepatology (2003) 38:1188–98. doi: 10.1053/
jhep.2003.50472
59. Miyazaki H, Sawada T, Kiyohira M, Yu Z, Nakamura K, Yasumoto Y, et al.
Fatty Acid Binding Protein 7 Regulates Phagocytosis and Cytokine
Production in Kupffer Cells During Liver Injury. Am J Pathol (2014)
184:2505–15. doi: 10.1016/j.ajpath.2014.05.015
60. Sitia G, Iannacone M, Aiolfi R, Isogawa M, van Rooijen N, Scozzesi C, et al.
Kupffer Cells Hasten Resolution of Liver Immunopathology in Mouse Models
of Viral Hepatitis. PloS Pathog (2011) 7:e1002061. doi: 10.1371/journal.
ppat.1002061
61. Tian Y, Kuo C, Akbari O, Ou JJ. Maternal-Derived Hepatitis B Virus E
Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence
After Vertical Transmission. Immunity (2016) 44:1204–14. doi: 10.1016/
j.immuni.2016.04.008
62. Ginhoux F, Bleriot C, Lecuit M. Dying for a Cause: Regulated Necrosis of
Tissue-Resident Macrophages Upon Infection. Trends Immunol (2017)
38:693–5. doi: 10.1016/j.it.2017.05.009
63. Guillot A, Tacke F. Liver Macrophages: Old Dogmas and New Insights.
Hepatol Commun (2019) 3:730–43. doi: 10.1002/hep4.1356
64. Holt MP, Cheng L, Ju C. Identification and Characterization of Infiltrating
Macrophages in Acetaminophen-Induced Liver Injury. J Leukoc Biol (2008)
84:1410–21. doi: 10.1189/jlb.0308173
65. Dambach DM, Watson LM, Gray KR, Durham SK, Laskin DL. Role of CCR2
in Macrophage Migration Into the Liver During Acetaminophen-Induced
Hepatotoxicity in the Mouse. Hepatology (2002) 35:1093–103. doi: 10.1053/
jhep.2002.33162
66. You Q, Holt M, Yin H, Li G, Hu C-J, Ju C. Role of Hepatic Resident and
Infiltrating Macrophages in Liver Repair After Acute Injury. Biochem
Pharmacol (2013) 86:836–43. doi: 10.1016/j.bcp.2013.07.006
67. Emmanuilidis K, Weighardt H, Maier S, Gerauer K, Fleischmann T, Zheng
XX, et al. Critical Role of Kupffer Cell-Derived IL-10 for Host Defense in
Septic Peritonitis. J Immunol (2001) 167:3919–27. doi: 10.4049/jimmunol.
167.7.3919
68. Breous E, Somanathan S, Vandenberghe LH, Wilson JM. Hepatic Regulatory
T Cells and Kupffer Cells Are Crucial Mediators of Systemic T Cell Tolerance
to Antigens Targeting Murine Liver. Hepatology (2009) 50:612–21. doi:
10.1002/hep.23043June 2021 | Volume 12 | Article 690813
Zwicker et al. Hepatic Macrophage Heterogeneity and Plasticity69. Ju C, Reilly TP, Bourdi M, Radonovich MF, Brady JN, George JW, et al.
Protective Role of Kupffer Cells in Acetaminophen-Induced Hepatic Injury in
Mice. Chem Res Toxicol (2002) 15:1504–13. doi: 10.1021/tx0255976
70. Campion SN, Johnson R, Aleksunes LM, GoedkenMJ, van Rooijen N, Scheffer
GL, et al. Hepatic Mrp4 Induction Following Acetaminophen Exposure is
Dependent on Kupffer Cell Function. Am J Physiol Gastrointest Liver Physiol
(2008) 295:G294–304. doi: 10.1152/ajpgi.00541.2007
71. Jetten N, Donners MMPC, Wagenaar A, Cleutjens JPM, van Rooijen N, de
Winther MPJ, et al. Local Delivery of Polarized Macrophages Improves
Reperfusion Recovery in a Mouse Hind Limb Ischemia Model. PloS One
(2013) 8:e68811. doi: 10.1371/journal.pone.0068811
72. Kolodziejczyk AA, Federici S, Zmora N, Mohapatra G, Dori-Bachash M, Hornstein
S, et al. Acute Liver Failure is Regulated by MYC- and Microbiome-Dependent
Programs. Nat Med (2020) 26:1899–911. doi: 10.1038/s41591-020-1102-2
73. Davies LC, Rosas M, Jenkins SJ, Liao C-T, Scurr MJ, Brombacher F, et al.
Distinct Bone Marrow-Derived and Tissue-Resident Macrophage Lineages
Proliferate at Key Stages During Inflammation. Nat Commun (2013) 4:1886.
doi: 10.1038/ncomms2877
74. Gautier EL, Ivanov S, Lesnik P, Randolph GJ. Local Apoptosis Mediates
Clearance of Macrophages From Resolving Inflammation in Mice. Blood
(2013) 122:2714–22. doi: 10.1182/blood-2013-01-478206
75. XiongX,KuangH,Ansari S, LiuT,Gong J,WangS, et al. Landscapeof Intercellular
Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene
Analysis.Mol Cell (2019) 75:644–660.e5. doi: 10.1016/j.molcel.2019.07.028
76. Krenkel O, Hundertmark J, Abdallah AT, Kohlhepp M, Puengel T, Roth T,
et al. Myeloid Cells in Liver and Bone Marrow Acquire a Functionally Distinct
Inflammatory Phenotype During Obesity-Related Steatohepatitis. Gut (2020)
69:551–63. doi: 10.1136/gutjnl-2019-318382
77. Schneider KM, Elfers C, Ghallab A, Schneider CV, Galvez EJC, Mohs A, et al.
Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury. Cell
Mol Gastroenterol Hepatol (2021) 11:909–33. doi: 10.1016/j.jcmgh.2020.11.002
78. Gong S, Lan T, Zeng L, Luo H, Yang X, Li N, et al. Gut Microbiota Mediates
Diurnal Variation of Acetaminophen Induced Acute Liver Injury in Mice.
J Hepatol (2018) 69:51–9. doi: 10.1016/j.jhep.2018.02.024
79. McDonald B, Zucoloto AZ, Yu I-L, Burkhard R, Brown K, Geuking MB, et al.
Programing of an Intravascular Immune Firewall by the Gut Microbiota
Protects Against Pathogen Dissemination During Infection. Cell Host Microbe
(2020) 28:660–8.e4. doi: 10.1016/j.chom.2020.07.014
80. David BA, Rezende RM, Antunes MM, Santos MM, Lopes MAF, Diniz AB,
et al. Combination of Mass Cytometry and Imaging Analysis Reveals Origin,
Location, and Functional Repopulation Of Liver Myeloid Cells in Mice.
Gastroenterology (2016) 151:1176–91. doi: 10.1053/j.gastro.2016.08.024
81. Borst K, Frenz T, Spanier J, Tegtmeyer P-K, Chhatbar C, Skerra J, et al. Type I
Interferon Receptor Signaling Delays Kupffer Cell Replenishment During
Acute Fulminant Viral Hepatitis. J Hepatol (2018) 68:682–90. doi: 10.1016/
j.jhep.2017.11.029
82. Anthony BJ, Ramm GA, McManus DP. Role of Resident Liver Cells in the
Pathogenesis of Schistosomiasis. Trends Parasitol (2012) 28:572–9. doi:
10.1016/j.pt.2012.09.005Frontiers in Immunology | www.frontiersin.org 1583. Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R,
Wynn TA. Immunopathology of Schistosomiasis. Immunol Cell Biol (2007)
85:148–54. doi: 10.1038/sj.icb.7100014
84. Barron L, Wynn TA. Macrophage Activation Governs Schistosomiasis-
Induced Inflammation and Fibrosis. Eur J Immunol (2011) 41:2509–14. doi:
10.1002/eji.201141869
85. Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, van Rooijen N,
et al. Local Macrophage Proliferation, Rather Than Recruitment From the
Blood, is a Signature of TH2 Inflammation. Science (2011) 332:1284–8. doi:
10.1126/science.1204351
86. Jenkins SJ, Ruckerl D, Thomas GD, Hewitson JP, Duncan S, Brombacher F,
et al. IL-4 Directly Signals Tissue-Resident Macrophages to Proliferate Beyond
Homeostatic Levels Controlled by CSF-1IL-4 Drives Macrophage
Proliferation. J Exp Med (2013) 210:2477–91. doi: 10.1084/jem.20121999
87. Girgis NM, Gundra UM, Ward LN, Cabrera M, Frevert U, Loke P. Ly6chigh
Monocytes Become Alternatively Activated Macrophages in Schistosome
Granulomas With Help From CD4+ Cells. PloS Pathog (2014) 10:e1004080.
doi: 10.1371/journal.ppat.1004080
88. Nascimento M, Huang SC, Smith A, Everts B, Lam W, Bassity E, et al. Ly6chi
Monocyte Recruitment Is Responsible for Th2 Associated Host-Protective
Macrophage Accumulation in Liver Inflammation Due to Schistosomiasis.
PloS Pathog (2014) 10:e1004282. doi: 10.1371/journal.ppat.1004282
89. Itoh M, Kato H, Suganami T, Konuma K, Marumoto Y, Terai S, et al. Hepatic
Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic
Steatohepatitis in Mice and Humans. PloS One (2013) 8:e82163. doi:
10.1371/journal.pone.0082163
90. Itoh M, Suganami T, Kato H, Kanai S, Shirakawa I, Sakai T, et al. CD11c+
Resident Macrophages Drive Hepatocyte Death-Triggered Liver Fibrosis in a
Murine Model of Nonalcoholic Steatohepatitis. JCI Insight (2017) 2:e92902.
doi: 10.1172/jci.insight.92902
91. Jaitin DA, Adlung L, Thaiss CA, Weiner A, Li B, Descamps H, et al. Lipid-
Associated Macrophages Control Metabolic Homeostasis in a Trem2-
Dependent Manner. Cell (2019) 178:686–98.e14. doi: 10.1016/j.cell.
2019.05.054
92. Satoh T, Nakagawa K, Sugihara F, Kuwahara R, Ashihara M, Yamane F, et al.
Identification of an Atypical Monocyte and Committed Progenitor Involved
in Fibrosis. Nature (2017) 541:96–101. doi: 10.1038/nature20611Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Zwicker, Bujko and Scott. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original author(s)
and the copyright owner(s) are credited and that the original publication in this journal is
cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.June 2021 | Volume 12 | Article 690813
